197 related articles for article (PubMed ID: 35887466)
1. COVID-19-Associated Pulmonary Mucormycosis.
Krishna V; Bansal N; Morjaria J; Kaul S
J Fungi (Basel); 2022 Jul; 8(7):. PubMed ID: 35887466
[TBL] [Abstract][Full Text] [Related]
2. Critical COVID-19-associated pulmonary mucormycosis: The underreported life-threatening spectrum of the mucormycosis epidemic.
Mehta RM; Bansal S; Kalpakkam H
Lung India; 2022; 39(2):187-190. PubMed ID: 35259803
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of Mucormycosis Before and During COVID-19: Epidemiology, Diagnosis, and Current Therapeutic Interventions.
Mansoor S; Ahmed TI; Happa K; Sultan M; Manhas S; Shamas S
Curr Fungal Infect Rep; 2022; 16(4):131-142. PubMed ID: 35967987
[TBL] [Abstract][Full Text] [Related]
4. Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.
Kamrul-Hasan AB; Selim S
Mymensingh Med J; 2021 Jul; 30(3):874-880. PubMed ID: 34226483
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
6. Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India.
Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Singh Sibia RP; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
Clin Microbiol Infect; 2024 Mar; 30(3):368-374. PubMed ID: 38081413
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and mucormycosis superinfection: the perfect storm.
Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.
Pruthi H; Muthu V; Bhujade H; Sharma A; Baloji A; Ratnakara RG; Bal A; Singh H; Sandhu MS; Negi S; Chakrabarti A; Singhal M
Mycopathologia; 2022 Feb; 187(1):31-37. PubMed ID: 34936060
[TBL] [Abstract][Full Text] [Related]
10. Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.
Kamath S; Kumar M; Sarkar N; Ahmed T; Sunder A
Cureus; 2022 Jan; 14(1):e21054. PubMed ID: 35155019
[TBL] [Abstract][Full Text] [Related]
11. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology, Clinical Features and Management of Rhino Orbital Mucormycosis in Post COVID 19 Patients.
Desai EJ; Pandya A; Upadhya I; Patel T; Banerjee S; Jain V
Indian J Otolaryngol Head Neck Surg; 2022 Mar; 74(1):103-107. PubMed ID: 34414101
[TBL] [Abstract][Full Text] [Related]
13. Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes.
Janjua OS; Shaikh MS; Fareed MA; Qureshi SM; Khan MI; Hashem D; Zafar MS
J Fungi (Basel); 2021 Dec; 8(1):. PubMed ID: 35049983
[TBL] [Abstract][Full Text] [Related]
14. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
[TBL] [Abstract][Full Text] [Related]
15. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.
Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM
Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 associated pulmonary mucormycosis: A systematic review of published cases with review of literature.
Rai DK
J Family Med Prim Care; 2022 Apr; 11(4):1244-1249. PubMed ID: 35516689
[TBL] [Abstract][Full Text] [Related]
17. Invasive Fungal Infections Complicating COVID-19: A Narrative Review.
Casalini G; Giacomelli A; Ridolfo A; Gervasoni C; Antinori S
J Fungi (Basel); 2021 Oct; 7(11):. PubMed ID: 34829210
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: A Proposed Classification and Treatment Strategies.
Kant Singh N; Hage N; Ramamourthy B; Medha Kappagantu K
Infect Disord Drug Targets; 2022; 22(8):1-7. PubMed ID: 35400327
[TBL] [Abstract][Full Text] [Related]
19. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.
Muthu V; Agarwal R; Patel A; Kathirvel S; Abraham OC; Aggarwal AN; Bal A; Bhalla AS; Chhajed PN; Chaudhry D; Garg M; Guleria R; Krishnan RG; Kumar A; Maheshwari U; Mehta R; Mohan A; Nath A; Patel D; Rudramurthy SM; Saxena P; Sethuraman N; Singhal T; Soman R; Thangakunam B; Varghese GM; Chakrabarti A
Lancet Infect Dis; 2022 Sep; 22(9):e240-e253. PubMed ID: 35390293
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.
Avatef Fazeli M; Rezaei L; Javadirad E; Iranfar K; Khosravi A; Amini Saman J; Poursabbagh P; Ghadami MR; Parandin MM; Dehghani A; Ahmadi Jouybari T; Mahdavian B; Eivazi N; Rezaei S; Rezaei A; Emami B; Haqgou M; Bozorgomid A; Sayad B
Mycoses; 2021 Nov; 64(11):1366-1377. PubMed ID: 34252988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
